ESSA Pharma Total Current Liabilities Over Time
EPIX Stock | USD 6.75 0.10 1.50% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ESSA Pharma Performance and ESSA Pharma Correlation. ESSA |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.14) | Return On Equity (0.19) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Current Liabilities Analysis
Compare ESSA Pharma and related stocks such as Altamira Therapeutics, Summit Therapeutics PLC, and Avenue Therapeutics Total Current Liabilities Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CYTO | 713.2 K | 713.2 K | 867.1 K | 16.6 M | 4.4 M | 6.2 M | 9 M | 10.4 M | 4.6 M | 2.3 M | 3 M | 4.9 M | 12.9 M | 888.9 K | 844.5 K |
SMMT | 3.6 K | 2 M | 2.4 M | 3.1 M | 5.7 M | 4.6 M | 13.6 M | 26.8 M | 16.9 M | 12.7 M | 19.9 M | 25.6 M | 38.8 M | 20.4 M | 11 M |
ATXI | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 6.4 M | 2.8 M | 5.2 M | 2.1 M | 886 K | 509 K | 3.6 M | 1.2 M | 2.2 M |
SPRO | 6.4 M | 6.4 M | 6.4 M | 6.4 M | 6.4 M | 6.4 M | 6.9 M | 8.2 M | 12.3 M | 26.7 M | 14.3 M | 18.7 M | 21.6 M | 37.2 M | 18.6 M |
ESSA Pharma and related stocks such as Altamira Therapeutics, Summit Therapeutics PLC, and Avenue Therapeutics Total Current Liabilities description
Total Current Liabilities is an item on ESSA Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ESSA Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.My Equities
My Current Equities and Potential Positions
ESSA Pharma | EPIX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | British Columbia; Canada |
Exchange | NASDAQ Exchange |
USD 6.75
Check out ESSA Pharma Performance and ESSA Pharma Correlation. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
ESSA Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.